Target intelligence / Profile preview

Gamma-aminobutyric acid receptor subunit B (GABAB2) (GABAB2)

Target
GABAB2
Molecular classification
G protein-coupled receptor
01

Overview

The gamma-aminobutyric acid receptor subunit B, commonly known as GABAB2 or the R2 subunit, forms an obligate heterodimer with the GABAB1 (R1) subunit to create the functional metabotropic GABAB receptor, a class C G protein-coupled receptor (GPCR) that mediates slow inhibitory neurotransmission in the central nervous system. GABAB2 contains an extracellular Venus flytrap domain connected via a unique stalk to a seven-transmembrane domain, with its C-terminus facilitating heterodimerization through a coiled-coil motif and G protein coupling primarily via Gi/o proteins, which inhibit adenylyl cyclase and modulate ion channels like GIRK and voltage-gated calcium channels. This subunit is essential for trafficking the heterodimer to the plasma membrane, as GABAB1 alone is retained in the endoplasmic reticulum, and it hosts allosteric binding sites for positive modulators within the transmembrane domain interface. GABAB receptors, including GABAB2, are implicated in various neurological diseases due to their roles in modulating neuronal excitability presynaptically and postsynaptically. Drugs like baclofen act as orthosteric agonists binding to GABAB1 but require GABAB2 for downstream signaling, while allosteric modulators like GS39783 enhance receptor activity at the GABAB2-involved sites, offering therapeutic potential in conditions such as spasticity, addiction, and pain.

Other names
GABA_B2GABAB R2GBR2R2 subunit
02

Mechanism of action

Metabotropic receptor agonist at orthosteric site in Venus flytrap domain of GABAB1 (with GABAB2 required for functional signaling), Positive allosteric modulation at transmembrane domain interface

03

Biological functions

Signal transduction
04

Disease associations

Neurological disease
05

Interacting drugs

(R)-Baclofen

4 more in the full profile.

Beyond the preview

Go deeper on Gamma-aminobutyric acid receptor subunit B (GABAB2) (GABAB2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gamma-aminobutyric acid receptor subunit B (GABAB2) (GABAB2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call